Pharma Mar Competitors and Similar CompaniesClear all

Pharma Mar's competitors and similar companies include Castle Biosciences, BioInvent and Inventiva.

	Pharma Mar Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs.	Castle Biosciences Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.	BioInvent BioInvent focuses on the discovery and development of antibody-based drugs against cancer.	Inventiva Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.
Founding Date	Founding Date 1986	Founding Date 2008	Founding Date 1997	Founding Date 2011
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare Manufacturing & Industrial biotech chemicals drug development home care medical diagnostics oncology pharma	Tags Healthcare biotech medical diagnostics medtech oncology	Tags Healthcare biotech drug development medical diagnostics oncology pharma	Tags Healthcare biotech clinical research drug development medical diagnostics oncology pharma
Locations	Locations Colmenar Viejo, ES HQ Madrid, ES	Locations Friendswood, US HQ Phoenix, US	Locations Lund, SE HQ	Locations Daix, FR HQ
Employees	Employees 500	Employees 61013% increase	Employees 118	Employees 114
Valuation ($)	Valuation ($) 1.4 b	Valuation ($) 936.9 m	Valuation ($) 285.9 m	Valuation ($) 231 m
Financial
Revenue (est.)	Revenue (est.) €221.4m (FY, 2025)	Revenue (est.) $344.2m (FY, 2025)	Revenue (est.) kr226.5m (FY, 2025)	Revenue (est.) €4.5m (FY, 2025)
Cost of goods	Cost of goods €12.3m (FY, 2025)	Cost of goods $71m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit €232m (FY, 2025)	Gross profit $273.2m (FY, 2025)	Gross profit kr226.6m (FY, 2025)	Gross profit €7.9m (FY, 2025)
Net income	Net income €75m (FY, 2025)	Net income ($24.2m) (FY, 2025)	Net income (kr332.9m) (FY, 2025)	Net income (€354.1m) (FY, 2025)